FLHLF News and Press, Filament Health From 09/21/23

Magdalena Biosciences is focused on developing novel, natural prescription medicines derived from plants for mental health indications Import of coca leaves was authorized by the Peruvian Health Authority SAN FRANCISCO, CA / ACCESSWIRE / September 21, 2023 / Jaguar Health, Inc. (NASD...

--News Direct-- Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to announce a significant licensing agreement between Filament Health and Reset Pharmaceuticals. The agreement involves the licensing of Filament Health's proprietary botanical psilocybin drug candid...

FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA Canada NewsWire Reset Pharma has licensed Filament's botanical psilocybin drug candidate for a phase 2 clinical trial studying demoralization syndrome VANCOUVER, BC , Aug. 31, 2023 /CNW/ - F...

FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF SEC REGISTRATION STATEMENT Canada NewsWire VANCOUVER, BC , Aug. 15, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a...

FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND REFILES Q1 2023 INTERIM FINANCIAL STATEMENTS AND MD&A FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND REFILES Q1 2023 INTERIM FINANCIAL STATEMENTS AND MD&A Canada NewsWire VANCO...

FILAMENT HEALTH ANNOUNCES FDA APPROVAL OF TWO CLINICAL TRIALS STUDYING ITS BOTANICAL PSILOCYBIN DRUG CANDIDATE PEX010 Canada NewsWire The University of Washington and the University of California, Los Angeles have been approved to study PEX010 in clinical trials for me...

VANCOUVER, BC / ACCESSWIRE / July 25, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Etruscus Resources, Filament Health and Lancaster Resources discussing their latest news. The Power Play by The Market Herald provides investors with a quick snapsho...

FILAMENT HEALTH ANNOUNCES UPSIZING AND CLOSING OF $2,500,000 NON-BROKERED PRIVATE PLACEMENT FINANCING Canada NewsWire Financing led by psychedelic investment fund Negev Capital VANCOUVER, BC , July 24, 2023 /CNW/ - Filament Health Corp. (OTCQB: FL...

FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING OF UP TO C$2,000,000 Canada NewsWire Financing led by premier psychedelics focused investment fund Negev Capital VANCOUVER, BC , July 19, 2023 /CNW/ - Filament Health Corp. (...

FILAMENT HEALTH CORP. TO LIST ON NASDAQ THROUGH BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION Canada NewsWire Business combination ascribes Filament US$176 million in equity value representing US$0.85 per Filament share and reflects a pro forma enterprise v...